SuperworthPulmonx profit margin LUNG
Gross, operating and net profit as a share of revenue over the last twelve months, from 2019.
- Net margin, 12 months
- −55.0%
- Operating margin, 12 months
- −53.0%
- Net margin on a year earlier
- +7.9 pts
- Peer median
- 6.9%
Over the twelve months to Jun 30, 2026, Pulmonx kept −55.0% of its revenue as net profit, with an operating margin of −53.0% and a gross margin of 77.1%.
Five years earlier its net margin was −92.2%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −59.7% | −59.3% | 74.2% |
| FY2024 | −67.3% | −68.9% | 74.0% |
| FY2023 | −88.6% | −90.2% | 73.9% |
| FY2022 | n/a | n/a | 74.3% |
| FY2021 | n/a | −97.7% | 73.6% |
| FY2020 | −98.5% | −98.8% | 64.8% |
| FY2019 | −63.5% | n/a | 68.8% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −55.0% | +7.9 pts | −53.0% | |
| Q1 FY26 | −60.1% | +5.2 pts | −58.8% | |
| Q4 FY25 | −59.7% | +7.6 pts | −59.3% | |
| Q3 FY25 | −61.9% | +10.1 pts | −62.4% | |
| Q2 FY25 | −62.9% | +12.7 pts | −62.9% | |
| Q1 FY25 | −65.3% | +15.2 pts | −66.0% | |
| Q4 FY24 | −67.3% | +21.3 pts | −68.9% | |
| Q3 FY24 | −72.0% | +22.5 pts | −73.4% | |
| Q2 FY24 | −75.6% | +24.2 pts | −77.4% | |
| Q1 FY24 | −80.5% | n/a | −82.3% | |
| Q4 FY23 | −88.6% | n/a | −90.2% | |
| Q3 FY23 | −94.5% | n/a | −96.6% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pulmonx's size, closest first, today.
| Company | Profit margin |
|---|---|
| LUNGPulmonx | −55.0% |
| KEQUKewaunee Scientific | 3.0% |
| APTAlpha Pro Tech | 6.8% |
| NEPHNephros | 8.4% |
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| Peer median | 6.9% |
Where Pulmonx ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Pulmonx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.